Simplify Logo

Full-Time

Senior Director

IT Infrastructure, UX & Security

Posted on 2/14/2024

Tessera Therapeutics

Tessera Therapeutics

201-500 employees

Develops gene writing genome engineering technology

Data & Analytics
Hardware
Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Category
Cybersecurity
IT Project Management
IT & Security
Required Skills
Management
Requirements
  • BS/BA degree in Computer Science, Business Information Systems, or another related field
  • 15+ years of hands-on IT management experience
  • Minimum of 5 years experience in the biotech and/or pharmaceutical industry
  • Extensive and hands-on expertise in business systems requirements, roadmaps, implementation & operations in a Biotech setting
  • Experience with end user computing systems, identity management, SAAS applications, and migrating to a Microsoft-centric environment
  • Experience with cloud computing, networking, and information security
  • Experience managing technology projects
  • Extensive vendor management experience
  • Strong interpersonal and relationship management skills
Responsibilities
  • Collaborate with company stakeholders to define business systems roadmaps
  • Responsible for implementation and operation of all site and company infrastructure
  • Responsible for overall IT process development, documentation & oversight
  • Coordinate, implement, and manage cross-enterprise IT projects
  • Coordinate with stakeholders on implementation of security policies
  • Develop productive and strong company end user, executive, internal stakeholder, vendor, and partner relationships
  • Work with company finance and contracts teams for all IT-related budget planning

Tessera Therapeutics is pioneering Gene Writing™, a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. They are focused on expanding possibilities in genetic medicine through tissue-targeted non-viral delivery technology, addressing major unmet medical needs with potentially curative and accessible therapies.

Company Stage

Series C

Total Funding

$581.7M

Headquarters

Cambridge, Massachusetts

Founded

2018

Growth & Insights
Headcount

6 month growth

-3%

1 year growth

0%

2 year growth

39%
INACTIVE